Related Experiment Video

Updated: Jun 9, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Congenital lymphedema with tuberous sclerosis and clinical Hirschsprung disease

Michael Lucas1, Yohanna Andrade

  • 1St. Peter's University Hospital, New Brunswick, New Jersey 08901, USA. mlucas@saintpetersuh.com

Pediatric Dermatology
|August 27, 2010
PubMed

Insights

This case study details an 18-month-old child diagnosed with congenital lymphedema, tuberous sclerosis, and Hirschsprung disease. It highlights the complex interplay of these rare conditions in early childhood development.

Area of Science:

  • Pediatric Medicine
  • Genetics
  • Developmental Biology

Background:

  • Congenital lymphedema presents as a rare condition affecting lymphatic system development.
  • Tuberous sclerosis is a genetic disorder causing tumors in various organs.
  • Hirschsprung disease involves congenital absence of nerve cells in the colon.

Observation:

  • An 18-month-old child presented with symptoms indicative of congenital lymphedema.
  • Further diagnostic evaluations revealed co-occurring tuberous sclerosis and Hirschsprung disease.
  • This constellation of diagnoses suggests potential shared underlying genetic or developmental pathways.

Findings:

  • The case illustrates a rare co-occurrence of three distinct congenital disorders.
  • Diagnostic challenges in identifying multiple rare diseases simultaneously are highlighted.
  • The patient's clinical course underscores the importance of comprehensive genetic and systemic evaluation.

Implications:

  • This case expands the understanding of phenotypic variability in tuberous sclerosis and Hirschsprung disease.
  • It may inform diagnostic protocols for children presenting with congenital lymphedema.
  • Further research into shared etiological factors could advance pediatric rare disease management.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Development of the Lymphatic System01:15

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...